Literature DB >> 11699140

[Blocking secretion of exocrine glands in the head-neck area by administration of botulinum toxin A. Therapy of a rare disease picture].

M Ellies1, R Laskawi, S Rohrbach-Volland, R Rödel, W Beuche.   

Abstract

BACKGROUND: Hypersecretion disorders of the exocrine glands of the head and neck area are a therapeutic problem in the field of otorhinolaryngology. In the present study, we demonstrate the effectiveness of local injections of botulinum toxin A to block secretions of exocrine glands of the head and neck area. PATIENTS AND METHODS: Four patients suffering from hypersecretion disorders received local injections of botulinum toxin A. Two patients suffered from disorders of the salivary glands: one presented an idiopathic hypersialorrhea and another a salivary fistula after parotidectomy. A third patient suffered from epiphora and a further patient presented severe hyperhidrosis on the pilose head region. In a retrospective clinical study, the outcome of therapy was evaluated by clinical examination and chemical parameters.
RESULTS: Clear blocking of secretion in the treated glands could be demonstrated in all four cases. Possible side effects of the treatment could not be observed.
CONCLUSIONS: The present study was able to demonstrate a clear blocking of secretion of the exocrine glands of the head and neck region through botulinum toxin A, offering an improvement in therapy especially for the innovative indication of blocking the salivary glands of the head.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11699140     DOI: 10.1007/s001060170028

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  7 in total

1.  Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.

Authors:  Dirk Dressler
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

2.  [Botulinum toxin A as a treatment of traumatic salivary gland fistulas].

Authors:  T Breuer; A Ferrazzini; R Grossenbacher
Journal:  HNO       Date:  2006-05       Impact factor: 1.284

Review 3.  Modern management of obstructive salivary diseases.

Authors:  P Capaccio; S Torretta; F Ottavian; G Sambataro; L Pignataro
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-08       Impact factor: 2.124

4.  Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea.

Authors:  Susanne Steinlechner; Christine Klein; Andreas Moser; Rebekka Lencer; Johann Hagenah
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

5.  Intraglandular injection of botulinum toxin a reduces tear production in rabbits.

Authors:  Anna M Demetriades; Ilya M Leyngold; Sam D'Anna; Allen O Eghrari; Dave G Emmert; Michael P Grant; Shannath L Merbs
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2013 Jan-Feb       Impact factor: 1.746

6.  [Local botulinum toxin A for treating chronic sialorrhea].

Authors:  E Krause; K Bötzel; R de la Chaux; R Gürkov
Journal:  HNO       Date:  2008-09       Impact factor: 1.284

Review 7.  Salivary gland diseases in children.

Authors:  Heinrich Iro; Johannes Zenk
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2014-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.